"These major differences in cardiotoxicity between HF and lumefantrine, which are very similar drugs, are consistent with the known lesser cardiotoxicity of HF racemic compound and/or the HF N-desbutyl metabolite compared to HF itself [18].HF is still used in countries such as Pakistan or parts of West and Central Africa, despite the availability of much safer options including the WHO recommended" . . . . .